Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT
Condition: Hyperparathyroidism; Secondary, Renal Intervention: Drug: Cinacalcet HCl Sponsor: Kyowa Hakko Kirin China Pharmaceutical Co.,LTD. Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2017 Category: Research Source Type: clinical trials